Table 4.

Allele and genotype frequencies of CETP TaqI B polymorphism in T2DM patients and controls after stratifying in male and female

	Male*				Female*
	Patient n (%)	Control n (%)	P-value	OR (95% CI)	Patient n (%)	Control n (%)	P-value	OR (95% CI)
B1B1	22 (27.8)	34 (29.3)	0.825	0.93 (0.49–1.76)	18 (31.6)	38 (25.7)	0.395	1.34 (0.68–2.61)
B1B2	44 (55.7)	60 (51.7)	0.585	1.17 (0.66–2.08)	29 (50.9)	74 (50.0)	0.910	1.04 (0.56–1.91)
B2B2	13 (16.5)	22 (19.0)	0.654	0.84 (0.40–1.79)	10 (17.5)	36 (24.3)	0.297	0.66 (0.30–1.44)
B1	88 (55.70)	128 (55.17)	0.920	1.02 (0.68–1.53)	65 (57.02)	150 (50.68)	0.249	1.29 (0.84–2.00)
B2	70 (44.30)	104 (44.83)	0.920	0.98 (0.65–1.47)	49 (42.98)	146 (49.32)	0.249	0.77 (0.50–1.20)

* Total male patients 79, controls 116 and total female patients 57, controls 148